These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 35163129)
1. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129 [TBL] [Abstract][Full Text] [Related]
2. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Ohmoto A; Yachida S; Morizane C Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699894 [TBL] [Abstract][Full Text] [Related]
3. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and Management of Hereditary Pancreatic Cancer. Humphris JL; Biankin AV Recent Results Cancer Res; 2016; 205():61-83. PubMed ID: 27075349 [TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines. Bennett C; Suguitan M; Abad J; Chawla A Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H; JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560 [TBL] [Abstract][Full Text] [Related]
17. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Furniss CS; Yurgelun MB; Ukaegbu C; Constantinou PE; Lafferty CC; Talcove-Berko ER; Schwartz AN; Stopfer JE; Underhill-Blazey M; Kenner B; Nelson SH; Okumura S; Law S; Zhou AY; Coffin TB; Rodriguez NJ; Uno H; Ocean AJ; McAllister F; Lowy AM; Lippman SM; Klein AP; Madlensky L; Petersen GM; Garber JE; Goggins MG; Maitra A; Syngal S Cancer Prev Res (Phila); 2021 Nov; 14(11):1021-1032. PubMed ID: 34625409 [TBL] [Abstract][Full Text] [Related]
18. Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes. Parkes A; Arun BK; Litton JK Oncologist; 2017 Jun; 22(6):655-666. PubMed ID: 28469042 [TBL] [Abstract][Full Text] [Related]
19. Hereditary breast cancer; Genetic penetrance and current status with BRCA. Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation. Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]